# Airsculpt Technologies, Inc.: financial statements, quarterly

AIRS · Nasdaq · CIK 1870940 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/airs.md) · [Financials](/companies/airs/financials.md) · [Filings](/companies/airs/filings.md) · [Insiders](/companies/airs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/airs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [46.8](/filings/0001870940-24-000045.md) | [47.6 d](/filings/0001870940-26-000021.md) | [47.6](/filings/0001870940-25-000021.md) | [51.0](/filings/0001870940-25-000031.md) | [42.5](/filings/0001870940-25-000040.md) | [39.2 d](/filings/0001870940-26-000021.md) | [39.4](/filings/0001870940-26-000028.md) | [44.0](/filings/0001870940-26-000038.md) | [35.0](/filings/0001870940-25-000040.md) | [33.4 d](/filings/0001870940-26-000021.md) | [39.4](/filings/0001870940-26-000028.md) | [42.9](/filings/0001870940-26-000038.md) |
| Selling, general and administrative | $m | [25.0](/filings/0001870940-24-000045.md) | [25.6 d](/filings/0001870940-26-000021.md) | [15.8](/filings/0001870940-25-000021.md) | [34.3](/filings/0001870940-25-000031.md) | [25.5](/filings/0001870940-25-000040.md) | [23.4 d](/filings/0001870940-26-000021.md) | [21.8](/filings/0001870940-26-000028.md) | [22.7](/filings/0001870940-26-000038.md) | [19.5](/filings/0001870940-25-000040.md) | [18.2 d](/filings/0001870940-26-000021.md) | [22.6](/filings/0001870940-26-000028.md) | [23.4](/filings/0001870940-26-000038.md) |
| Operating income | $m | [1.0](/filings/0001870940-24-000045.md) | [1.6 d](/filings/0001870940-26-000021.md) | [11.0](/filings/0001870940-25-000021.md) | [(5.0)](/filings/0001870940-25-000031.md) | [(3.7)](/filings/0001870940-25-000040.md) | [(3.9) d](/filings/0001870940-26-000021.md) | [(1.6)](/filings/0001870940-26-000028.md) | [0.8](/filings/0001870940-26-000038.md) | [(9.8)](/filings/0001870940-25-000040.md) | [(1.0) d](/filings/0001870940-26-000021.md) | [(1.8)](/filings/0001870940-26-000028.md) | [(0.0)](/filings/0001870940-26-000038.md) |
| Interest expense | $m | [1.8](/filings/0001870940-23-000051.md) | [1.0 d](/filings/0001870940-24-000005.md) | [1.5](/filings/0001870940-24-000030.md) | [1.5](/filings/0001870940-25-000031.md) | [1.6](/filings/0001870940-25-000040.md) | [1.6 d](/filings/0001870940-26-000021.md) | [1.6](/filings/0001870940-26-000028.md) | [1.6](/filings/0001870940-26-000038.md) | [1.4](/filings/0001870940-25-000040.md) | [1.5 d](/filings/0001870940-26-000021.md) | [1.2](/filings/0001870940-26-000028.md) | [1.0](/filings/0001870940-26-000038.md) |
| Income tax | $m | [0.8](/filings/0001870940-24-000045.md) | [5.0 d](/filings/0001870940-26-000021.md) | [3.5](/filings/0001870940-25-000021.md) | [(3.3)](/filings/0001870940-25-000031.md) | [0.7](/filings/0001870940-25-000040.md) | [(0.7) d](/filings/0001870940-26-000021.md) | [(0.4)](/filings/0001870940-26-000028.md) | [(0.2)](/filings/0001870940-26-000038.md) | [(1.6)](/filings/0001870940-25-000040.md) | [(3.8) d](/filings/0001870940-26-000021.md) | [(0.5)](/filings/0001870940-26-000028.md) | [(0.1)](/filings/0001870940-26-000038.md) |
| Net income | $m | [(1.7)](/filings/0001870940-24-000045.md) | [(4.3) d](/filings/0001870940-26-000021.md) | [6.0](/filings/0001870940-25-000040.md) | [(3.2)](/filings/0001870940-25-000040.md) | [(6.0)](/filings/0001870940-25-000040.md) | [(4.8) d](/filings/0001870940-26-000021.md) | [(2.8)](/filings/0001870940-26-000038.md) | [(0.6)](/filings/0001870940-26-000038.md) | [(9.5)](/filings/0001870940-25-000040.md) | [1.3 d](/filings/0001870940-26-000021.md) | [(2.4)](/filings/0001870940-26-000038.md) | [(1.1)](/filings/0001870940-26-000038.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0001870940-24-000045.md) | not reported | [0.10](/filings/0001870940-25-000021.md) | [(0.06)](/filings/0001870940-25-000031.md) | [(0.10)](/filings/0001870940-25-000040.md) | not reported | [(0.05)](/filings/0001870940-26-000028.md) | [(0.01)](/filings/0001870940-26-000038.md) | [(0.15)](/filings/0001870940-25-000040.md) | not reported | [(0.03)](/filings/0001870940-26-000028.md) | [(0.02)](/filings/0001870940-26-000038.md) |
| Basic EPS | $ per share | [(0.03)](/filings/0001870940-24-000045.md) | not reported | [0.10](/filings/0001870940-25-000021.md) | [(0.06)](/filings/0001870940-25-000031.md) | [(0.10)](/filings/0001870940-25-000040.md) | not reported | [(0.05)](/filings/0001870940-26-000028.md) | [(0.01)](/filings/0001870940-26-000038.md) | [(0.15)](/filings/0001870940-25-000040.md) | not reported | [(0.03)](/filings/0001870940-26-000028.md) | [(0.02)](/filings/0001870940-26-000038.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [8.7](/filings/0001870940-23-000051.md) | [10.3](/filings/0001870940-25-000008.md) | [11.0](/filings/0001870940-24-000030.md) | [9.9](/filings/0001870940-24-000035.md) | [6.0](/filings/0001870940-24-000045.md) | [8.2](/filings/0001870940-26-000021.md) | [5.6](/filings/0001870940-25-000021.md) | [8.2](/filings/0001870940-25-000031.md) | [5.4](/filings/0001870940-25-000040.md) | [8.4](/filings/0001870940-26-000038.md) | [16.7](/filings/0001870940-26-000028.md) | [18.8](/filings/0001870940-26-000038.md) |
| Current assets | $m | [16.4](/filings/0001870940-23-000051.md) | [16.0](/filings/0001870940-25-000008.md) | [15.0](/filings/0001870940-24-000030.md) | [21.7](/filings/0001870940-24-000035.md) | [12.9](/filings/0001870940-24-000045.md) | [17.1](/filings/0001870940-26-000021.md) | [15.3](/filings/0001870940-25-000021.md) | [16.4](/filings/0001870940-25-000031.md) | [12.2](/filings/0001870940-25-000040.md) | [15.5](/filings/0001870940-26-000038.md) | [24.3](/filings/0001870940-26-000028.md) | [27.5](/filings/0001870940-26-000038.md) |
| Total assets | $m | [204](/filings/0001870940-23-000051.md) | [204](/filings/0001870940-25-000008.md) | [203](/filings/0001870940-24-000030.md) | [210](/filings/0001870940-24-000035.md) | [208](/filings/0001870940-24-000045.md) | [213](/filings/0001870940-26-000021.md) | [203](/filings/0001870940-25-000021.md) | [198](/filings/0001870940-25-000031.md) | [186](/filings/0001870940-25-000040.md) | [187](/filings/0001870940-26-000038.md) | [192](/filings/0001870940-26-000028.md) | [193](/filings/0001870940-26-000038.md) |
| Current liabilities | $m | [19.8](/filings/0001870940-23-000051.md) | [20.3](/filings/0001870940-25-000008.md) | [21.8](/filings/0001870940-24-000030.md) | [25.1](/filings/0001870940-24-000035.md) | [25.3](/filings/0001870940-24-000045.md) | [28.9](/filings/0001870940-26-000021.md) | [26.8](/filings/0001870940-25-000021.md) | [25.8](/filings/0001870940-25-000031.md) | [24.2](/filings/0001870940-25-000040.md) | [27.9](/filings/0001870940-26-000038.md) | [32.5](/filings/0001870940-26-000028.md) | [34.9](/filings/0001870940-26-000038.md) |
| Total liabilities | $m | [120](/filings/0001870940-23-000051.md) | [120](/filings/0001870940-25-000008.md) | [119](/filings/0001870940-24-000030.md) | [125](/filings/0001870940-24-000035.md) | [126](/filings/0001870940-24-000045.md) | [135](/filings/0001870940-26-000021.md) | [126](/filings/0001870940-25-000021.md) | [107](/filings/0001870940-25-000031.md) | [104](/filings/0001870940-25-000040.md) | [99.6](/filings/0001870940-26-000038.md) | [91.7](/filings/0001870940-26-000028.md) | [88.4](/filings/0001870940-26-000038.md) |
| Long-term debt | $m | [70.6](/filings/0001870940-23-000051.md) | [69.5](/filings/0001870940-25-000008.md) | [68.5](/filings/0001870940-24-000030.md) | [67.5](/filings/0001870940-24-000035.md) | [66.4](/filings/0001870940-24-000045.md) | [65.5](/filings/0001870940-26-000021.md) | [64.3](/filings/0001870940-25-000021.md) | [53.2](/filings/0001870940-25-000031.md) | [51.9](/filings/0001870940-25-000040.md) | [50.6](/filings/0001870940-26-000038.md) | [39.4](/filings/0001870940-26-000028.md) | [33.1](/filings/0001870940-26-000038.md) |
| Current portion of debt | $m | [2.1](/filings/0001870940-23-000051.md) | [2.1](/filings/0001870940-25-000008.md) | [2.7](/filings/0001870940-24-000030.md) | [3.2](/filings/0001870940-24-000035.md) | [3.7](/filings/0001870940-24-000045.md) | [4.3](/filings/0001870940-26-000021.md) | [4.3](/filings/0001870940-25-000021.md) | [4.6](/filings/0001870940-25-000031.md) | [5.0](/filings/0001870940-25-000040.md) | [5.5](/filings/0001870940-26-000038.md) | [5.5](/filings/0001870940-26-000028.md) | [10.5](/filings/0001870940-26-000038.md) |
| Shareholders' equity | $m | [84.2](/filings/0001870940-24-000045.md) | [82.7](/filings/0001870940-26-000021.md) | [83.5](/filings/0001870940-25-000040.md) | [85.0](/filings/0001870940-25-000040.md) | [82.5](/filings/0001870940-25-000040.md) | [78.2](/filings/0001870940-26-000038.md) | [76.2](/filings/0001870940-26-000038.md) | [90.1](/filings/0001870940-26-000038.md) | [82.1](/filings/0001870940-25-000040.md) | [87.7](/filings/0001870940-26-000038.md) | [100](/filings/0001870940-26-000038.md) | [105](/filings/0001870940-26-000038.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [635 d](/filings/0001870940-24-000045.md) | [4,866 d](/filings/0001870940-26-000021.md) | [3,365](/filings/0001870940-25-000021.md) | [3,442 d](/filings/0001870940-25-000031.md) | [1,830 d](/filings/0001870940-25-000040.md) | [2,713 d](/filings/0001870940-26-000021.md) | [868](/filings/0001870940-26-000028.md) | [4,984 d](/filings/0001870940-26-000038.md) | [(225) d](/filings/0001870940-25-000040.md) | [(2,531) d](/filings/0001870940-26-000021.md) | [5,271](/filings/0001870940-26-000028.md) | [(1,238) d](/filings/0001870940-26-000038.md) |
| Capital expenditure | $k | [2,116 d](/filings/0001870940-24-000045.md) | [1,827 d](/filings/0001870940-26-000021.md) | [1,562](/filings/0001870940-25-000021.md) | [4,018 d](/filings/0001870940-25-000031.md) | [4,899 d](/filings/0001870940-25-000040.md) | [3,528 d](/filings/0001870940-26-000021.md) | [1,901](/filings/0001870940-26-000028.md) | [265 d](/filings/0001870940-26-000038.md) | [180 d](/filings/0001870940-25-000040.md) | [58.0 d](/filings/0001870940-26-000021.md) | [51.0](/filings/0001870940-26-000028.md) | [228 d](/filings/0001870940-26-000038.md) |
| Dividends paid | $k | [0.0 d](/filings/0001870940-24-000045.md) | [179 d](/filings/0001870940-26-000021.md) | [13.0](/filings/0001870940-25-000021.md) | [14.0](/filings/0001870940-25-000031.md) | [0.0](/filings/0001870940-25-000040.md) | [238 d](/filings/0001870940-26-000021.md) | [0.0](/filings/0001870940-25-000021.md) | [0.0](/filings/0001870940-25-000031.md) | [0.0](/filings/0001870940-25-000040.md) | [0.0 d](/filings/0001870940-26-000021.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [55.6](/filings/0001870940-23-000051.md) | [56.4](/filings/0001870940-24-000030.md) | [58.5](/filings/0001870940-24-000035.md) | [56.8](/filings/0001870940-24-000045.md) | [58.4](/filings/0001870940-25-000021.md) | [57.6](/filings/0001870940-25-000031.md) | [57.7](/filings/0001870940-25-000040.md) | [58.5](/filings/0001870940-26-000028.md) | [59.6](/filings/0001870940-26-000038.md) | [62.4](/filings/0001870940-25-000040.md) | [69.5](/filings/0001870940-26-000028.md) | [70.8](/filings/0001870940-26-000038.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 72,095,209 at 2026-08-07, from the cover of the [10-Q filed 2026-08-10](/filings/0001870940-26-000038.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.